Swiss medtech company Distalmotion SA closes USD 90m Series E Financing Round
26 January 2022 – Distalmotion SA, a young, international medical device company based in Lausanne, successfully closed its USD 90 million Series E financing round led by Revival Healthcare Capital.
Distalmotion is a medical device company founded and based in Lausanne, Switzerland, on a mission to remove the complexity out of robotic surgery in order to give all patients in general surgery, gynecology and urology access to best-in-class minimally invasive care. To do so, Distalmotion has developed a surgical robot called Dexter. Designed, developed and manufactured in Switzerland, Dexter combines the affordability of laparoscopy with the benefits of robotics through his novel approach to robotic surgery.
Walder Wyss advised Distalmotion in connection with the transaction. The team was led by Alex Nikitine (Corporate/M&A, Partner) and Dimitrios Berger (Corporate/M&A, Senior Associate) and further included Henriod Grégoire (Corporate/M&A, Managing Associate), Theodor Härtsch (Finance, Partner), Katrin Hagger (Finance, Associate), Markus Schülin (Notary, Counsel), Katja Schott-Morgenroth (Notary, Partner), André Kuhn (Notary, Managing Associate) and Delia Zellweger (Corporate/M&A, Trainee Lawyer).